Turning Point Therapeutics News

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:43 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:41 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:40 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:38 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:37 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:32 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:31 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:29 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:27 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:26 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 16:23 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jul 29, 2022 16:18 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 1, 2022 17:02 ET

Turning Point Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Sabus Steve M

Jun 1, 2022 16:59 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Apr 12, 2022 18:46 ET

Turning Point Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Sun Brian

Apr 12, 2022 18:44 ET

Turning Point Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(6.11%),Bihua Chen(6.11%), etc.

Feb 14, 2022 15:02 ET

Turning Point Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(7.7%)

Feb 14, 2022 14:35 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 11, 2022 18:11 ET

Turning Point Therapeutics | 4: Statement of changes in beneficial ownership of securities

Feb 11, 2022 18:10 ET